Crohn's & Colitis Foundation

FDA Approves Lilly's Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

Retrieved on: 
Thursday, October 26, 2023
Janus, Patient, FDA, Crohn's & Colitis Foundation, Eli Lilly and Company, Headache, Icahn School of Medicine at Mount Sinai, NYSE, Food, Lower respiratory tract infection, UC, UC-2, Hope, LLY, NRS, Infection, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Inflammation, Jaki, Ulcerative colitis, Rash, UC-1, Mount Sinai, Hepatotoxicity, Arthralgia, Immunology, Tuberculosis, European, Pharmaceutical industry, Lilly, Gastroenterology, Medicine

INDIANAPOLIS, Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh™ (mirikizumab-mrkz) infusion (300 mg/15 mL)/injection (100 mg/mL), the first and only interleukin-23p19 (IL-23p19) antagonist for the treatment of moderately to severely active ulcerative colitis (UC) in adults.

Key Points: 
  • "Today's approval represents a novel scientific advancement, providing a treatment that may offer relief from three key symptoms—stool frequency, rectal bleeding and bowel urgency—regardless of past biologic use."
  • All patients in the LUCENT program had past treatments, including biologic treatments, that did not work, stopped working or that they could not tolerate.
  • Patients in steroid-free clinical remission were steroid-free for at least three months prior to the end of the 52-week assessment.
  • "Bowel urgency is one of the most disruptive symptoms for patients with ulcerative colitis," said Michael Osso, president and chief executive officer, Crohn's & Colitis Foundation.

The Inner Circle Acknowledges, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology

Retrieved on: 
Tuesday, October 17, 2023
Faculty, Arizona State University Downtown Phoenix campus, American Association of Nurse Practitioners, American College, Geriatrics, Associate, Health, Nurse practitioner, Life, Reading, MD, RN, Certification, Practice, Multimedia, Crohn's disease, Injury, Inner circle, IBS, Crohn's & Colitis Foundation, American College of Gastroenterology, DNP, Love, IBD, University, Ferris State University, Music, Irritable bowel syndrome, American Gastroenterological Association, University of Michigan–Flint, Chron, Inflammatory bowel disease, Pediatrics, Emergency medicine, ICU, Nursing, Science, Gastroenterology

SHELBY TOWNSHIP, Mich., Oct. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology.

Key Points: 
  • SHELBY TOWNSHIP, Mich., Oct. 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Susan T. Wolgamott, DNP, FNP-C, CTN-B is acknowledged as a Top Pinnacle Healthcare Professional for her contributions to the field of Gastroenterology.
  • Later in 2010, she attended the University of Phoenix and received a Bachelor of Applied Science in Nursing.
  • She also served as a respected lecturer and professor at the University of Michigan-Flint from September 2011 to September 2020.
  • Dr. Wolgamott is a distinguished founding member and esteemed faculty of the Gastroenterology and Hepatology Advanced Practice Providers Organization.

EnLiSense CCM To Advance IBD Care with Innovative Sweat Sensor Studies, Teams Up with Leading Clinicians

Retrieved on: 
Wednesday, October 4, 2023
Technology, Biotechnology, Health, Other Health, Professional Services, Research, Medical Devices, Software, General Health, Data Analytics, Genetics, Health Technology, Science, Data Management, Brain-derived neurotrophic factor, University, Crohn's & Colitis Foundation, GFAP, IBD, University of Texas at Austin, Melatonin, Interleukin 6, Biomarker, Glial fibrillary acidic protein, IL6, University of Glasgow, Crohn's disease, Patient, CRP, Physician, Conditional sentence, Inflammatory bowel disease, BDNF, Glucose, Skin, C-reactive protein, Pharmaceutical industry, Medical imaging, Cortisol, Calprotectin, CCM

Patients and clinicians are now actively being enrolled in these studies, marking a pivotal phase in EnLiSense's journey towards revolutionizing chronic disease management.

Key Points: 
  • Patients and clinicians are now actively being enrolled in these studies, marking a pivotal phase in EnLiSense's journey towards revolutionizing chronic disease management.
  • The IBD Aware system, a cornerstone of EnLiSense's innovative approach, continuously monitors key inflammatory biomarkers by gently resting on a patient’s skin sampling just nano-liters of passive sweat.
  • This non-invasive, wearable technology empowers both clinicians and patients with real-time data, facilitating personalized, data-driven, proactive management of chronic diseases like IBD.
  • Dr. Sriram Muthukumar, CEO of EnLiSense CCM, reflects on the early findings, stating, "The initial validation data is indeed very encouraging.

"Golfluencer" Merch Teed Up to Boom According to Study from Roland DGA

Retrieved on: 
Tuesday, August 8, 2023
Heart, Partnership, Printing, Eye, Chungus, Research, Golf, Marketing, Sale, Crohn's disease, Crohn's & Colitis Foundation, Internet, Collection, Customer, Sport, Social media, Online shopping

IRVINE, Calif., Aug. 8, 2023 /PRNewswire-PRWeb/ -- More than half of US core golfers (55%) have bought merchandise from golf and sports social media influencers – golfluencers – as core golfers plan to spend as much as $40bn on golf-merchandise in the next 12 months*, according to a new study from Roland DGA and Censuswide. The research – a survey of core golfers (those that play at least 12 times a year) in the US – highlights how the rise of social media personalities means competition, or collaboration, for the likes of established golf brands.

Key Points: 
  • This partnership with Roland DGA has allowed me to launch a new, affordable range of Daddy Chungus gear and give back a little to my community."
  • Additionally, Roland DGA also recently released an in-depth white paper outlining how golf merchandise manufacturers can utilize product customization to increase customer engagement and profit.
  • Download the white paper here , or to learn more about the complete Roland DGA product line, visit http://www.rolanddga.com .
  • *The Roland DGA and Censuswide nationally representative survey found that, of the 16-and-older US population, 26.4m play golf more than 12 times per year.

Karen B. Rosenthal Recognized as a Notable Woman in Law by Crain's New York Business

Retrieved on: 
Monday, July 3, 2023
LLP, Lawyer, Woman, Organization, Crohn's & Colitis Foundation, Child, Divorce, AFCC, Entertainment, Family

NEW YORK, July 3, 2023 /PRNewswire-PRWeb/ -- Bikel, Rosenthal & Schanfield, LLP Partner Karen B. Rosenthal has been named to Crain's New York Business' list of Notable Women in Law for 2023. The annual list recognizes top women lawyers in New York City who demonstrate legal excellence, exemplary leadership skills, and a commitment to philanthropy and mentorship.

Key Points: 
  • Karen B. Rosenthal Recognized as a Notable Woman in Law by Crain's New York Business.
  • Bikel, Rosenthal & Schanfield LLP Partner Honored for Her Work on Behalf of Children in High-Conflict Divorce and Custody Cases
    NEW YORK, July 3, 2023 /PRNewswire-PRWeb/ -- Bikel, Rosenthal & Schanfield, LLP Partner Karen B. Rosenthal has been named to Crain's New York Business' list of Notable Women in Law for 2023.
  • The annual list recognizes top women lawyers in New York City who demonstrate legal excellence, exemplary leadership skills, and a commitment to philanthropy and mentorship.
  • Karen was recognized for her advocacy on behalf of children in high-conflict divorce and custody cases and her efforts to make divorce as painless as possible for children.

Cyltezo®, first and only FDA-approved Interchangeable biosimilar to Humira®, now commercially available in the U.S.

Retrieved on: 
Saturday, July 1, 2023
Crohn's & Colitis Foundation, National Psoriasis Foundation, Psoriatic arthritis, Interchangeability, Arthritis Foundation, Food and Drug Administration, Dermatology, Quality of life, American Academy, Colitis, Psoriasis, Crohn's disease, Boehringer Ingelheim, Patient, Risk, Phase, FDA, Health, Safety, Food, Management of Crohn's disease, Rheumatoid arthritis, Disease, Generic drug, Pharmaceutical industry, Adalimumab

Cyltezo was approved as an Interchangeable biosimilar in 2021, and is available as a prefilled syringe, or as a Cyltezo® Pen autoinjector.

Key Points: 
  • Cyltezo was approved as an Interchangeable biosimilar in 2021, and is available as a prefilled syringe, or as a Cyltezo® Pen autoinjector.
  • "Cyltezo is the first and only FDA-approved Interchangeable biosimilar to Humira® that is available to the millions of people in the U.S. living with certain chronic inflammatory diseases," said Stephen Pagnotta, Executive Director and Biosimilar Commercial Lead at Boehringer Ingelheim.
  • An Interchangeable biosimilar must first meet the high FDA standards of a biosimilar.
  • "For many people living with plaque psoriasis or psoriatic arthritis, finding effective relief from symptoms can be a daily struggle.

The Inner Circle Acknowledges, Darren N. Seril, MD, Ph.D., as a Top Pinnacle Provider for his contributions to the medical field

Retrieved on: 
Monday, April 17, 2023
Medical school, RWJBarnabas Health, Crohn's & Colitis Foundation, Gastroenterology, Doctor of Philosophy, American Gastroenterological Association, Pancreas, Human, Molecular Pharmacology, Esophagus, Mentorship, Disorder, Inner circle, Stomach, Colon, Rutgers University, Inflammatory bowel disease, Crohn's disease, Cleveland, Robert Wood Johnson University Hospital, Medical degree, Robert Wood Johnson Medical School, Thomas Jefferson University Hospital, Cleveland Clinic, Liver, Patient, American College of Gastroenterology, American College, Pharmacology, Nursing, MD, Biology, Medicine

PLAINFIELD, N.J., April 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Darren N. Seril, MD, Ph.D., is acknowledged as a Top Pinnacle Provider for his contributions to the medical field.

Key Points: 
  • PLAINFIELD, N.J., April 17, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Darren N. Seril, MD, Ph.D., is acknowledged as a Top Pinnacle Provider for his contributions to the medical field.
  • Dr. Seril earned a Bachelor of Science degree in Biology and a Ph.D. in Molecular Pharmacology from Rutgers University.
  • He received a Medical Degree from the Robert Wood Johnson School of Medicine and completed his internal medicine residency at Thomas Jefferson University Hospital in Philadelphia, PA.
  • He asserts that he has advanced training in this field and also teaches fellowship students who are training in this specialty.

KATE FARMS PARTNERS WITH PGA TOUR PLAYERS TO SPOTLIGHT INVISIBLE DISEASES

Retrieved on: 
Wednesday, April 5, 2023
Korn Ferry Tour Finals, Canada, Exercise, Learning, Korn Ferry, Partnership, Matthews, University, Crohn's & Colitis Foundation, Health, Florida State University, IBD, Mid-Tertiary ignimbrite flare-up, Sleep, Human, Research, PGA Tour, Korn Ferry Tour, Golf, Inflammation, Children's Hospital, Colitis, Abdominal pain, Crohn's disease, Athlete, CCF, FSU, Player, PGA Tour Canada, Diagnosis, PGA, Hospital, Hank Lebioda, Family, Conference, Dyeing, Central Florida

SANTA BARBARA, Calif., April 5, 2023 /PRNewswire/ -- Kate Farms® the market leader bringing plant-based nutrition into healthcare, today announced a partnership with PGA TOUR players Hank Lebioda and Brandon Matthews, to spotlight professional athletes with unique health conditions who use Kate Farms as part of their wellness and nutrition routines.

Key Points: 
  • Professional Golfers Hank Lebioda and Brandon Matthews Battle Crohn's, Colitis
    SANTA BARBARA, Calif., April 5, 2023 /PRNewswire/ -- Kate Farms ® the market leader bringing plant-based nutrition into healthcare, today announced a partnership with PGA TOUR players Hank Lebioda and Brandon Matthews , to spotlight professional athletes with unique health conditions who use Kate Farms as part of their wellness and nutrition routines.
  • After a diagnosis of Crohn's disease, Hank became diligent about his sleep, fitness, stress management and nutrition to avoid inflammation and flare-ups, earning his way onto the PGA TOUR in 2018 after strong showings on the Korn Ferry Tour, PGA TOUR Canada and PGA TOUR Latin America.
  • For Brandon Matthews, the 2022/2023 PGA TOUR season is his first, after multiple top-three finishes and one victory in Colombia on the Korn Ferry Tour last year to secure his PGA TOUR membership for the 2022/2023 season.
  • In 2021 Matthews was the Player of the Year on PGA TOUR Latin America.

THE HOWARD HUGHES CORPORATION® APPOINTS ANDREW SCHWARTZ AND ZACH WINICK CO-PRESIDENTS OF THE NEW YORK REGION

Retrieved on: 
Wednesday, February 1, 2023
Ice, NHL, Restaurant, City, New Jersey Devils, Senior ice hockey, New York Law School, National Hockey League, South Street Seaport, University, Howard Hughes Corporation, Water Street, Sirius XM, Communication, Leukemia, Marketing, NYSE, Edison Properties, Breast Cancer Research Foundation, Crohn's & Colitis Foundation, Football, Sale, Health, Senior, NBA, Pier, Major League Baseball, Brooklyn Nets, HHC, Tin, Strategic partnership, Hippodrome Theater (Cleveland, Ohio), Hockey, Partnership, Growth, Lawn, Jersey Devil, Fulton Market Building, Student Competition Center, Financial management, Leukemia & Lymphoma Society, Barclays Center, Sport, Breast cancer, Roof, Hotel, Nightclub, Drug, Midtown Manhattan, Lower Manhattan

NEW YORK, Feb. 1, 2023 /PRNewswire/ -- The Howard Hughes Corporation ® (NYSE: HHC) announced today that Andrew Schwartz and Zach Winick have been named Co-Presidents of the company's New York region and will lead the continued revitalization of the Seaport neighborhood in Lower Manhattan.

Key Points: 
  • NEW YORK, Feb. 1, 2023 /PRNewswire/ -- The Howard Hughes Corporation ® (NYSE: HHC) announced today that Andrew Schwartz and Zach Winick have been named Co-Presidents of the company's New York region and will lead the continued revitalization of the Seaport neighborhood in Lower Manhattan.
  • "We are fortunate to have Andrew and Zach taking the helm of our New York region as we enter this dynamic next chapter at the Seaport," said David R. O'Reilly, Chief Executive Officer of The Howard Hughes Corporation.
  • Mr. Schwartz has been with HHC at the Seaport since 2015, most recently serving as Executive Vice President of Strategic Partnerships.
  • "Over the past seven years, the Seaport has grown into one of New York City's most sought-after neighborhoods.

Public Interest Registry Names Five New Members to its Advisory Council

Retrieved on: 
Monday, November 21, 2022
Internet, Veteran, Trust, Public Interest Registry, Poverty, PIR, Crohn's & Colitis Foundation, Country code top-level domain, Policy, Council, Top-level domain, Registrar, ALAC, Arthritis Foundation, MarkMonitor, Advisory, Public relations, United States Olympic & Paralympic Committee, Woman, 501(c)(3) organization, Religion, Arthritis, Advisory Council, Multimedia, Life, SAS Institute, Telecommunication, Human, Visual impairment, Hunger, Organization, Human rights, Education, Culture, Politics, Kayla, Internet Society, Advisory Council on Historic Preservation, Pharmaceutical industry, Management, Property management, Optometry, ICANN

"We are honored to welcome our newest members to the Public Interest Registry Advisory Council from organizations around the world," said Jon Nevett, President and CEO of Public Interest Registry.

Key Points: 
  • "We are honored to welcome our newest members to the Public Interest Registry Advisory Council from organizations around the world," said Jon Nevett, President and CEO of Public Interest Registry.
  • The members are approved by the PIR Board of Directors in accordance with the Advisory Council Charter.
  • Public Interest Registry is proud to welcome the following new members to its Advisory Council:
    Andrea Abramowitz is from the United States and currently lives in Frisco, Texas.
  • In addition to these new members, the following current members will continue their service and round out the Advisory Council at nine members.